Previous reported study synthesized the triazolone bearing compound Gαq-RGS2 signaling inhibitor and extensively evaluated the pharmacological activity against the urinary incontinence, which showed the beneficial activity in the urinary incontinence [4]. The gene discussed is RGS2; the disease is Urinary incontinence.